user

An interim analysis of efficacy and safety from a randomized controlled trial of panitumumab with chemotherapy plus bevacizumab (BEV) in metastatic colorectal cancer (MCRC)

被引：0
|
作者：
Hecht, J. [1 ]
Chiciac, T. [1 ]
Mitchell, E. [1 ]
Stella, P. [1 ]
Cohn, A. [1 ]
McCollum, D. [1 ]
Saleh, M. [1 ]
Marshall, A. [1 ]
Shahin, S. [1 ]
Deeter, R. [1 ]
机构：
[1] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：VII21 / VII22
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of bevacizumab in metastatic colorectal cancer (mCRC): Pooled analysis from randomized controlled trials (RCTs)
    Christopher Tebbutt, Niall
    Hurwitz, Herbert
    Kabbinavar, Fairooz
    Giantonio, Bruce J.
    Guan, Zhongzhen
    Mitchell, Lada
    Waterkamp, Daniel
    Tabernero, Josep
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in metastatic colorectal cancer (mCRC): The phase II randomized MOMA trial
    Falcone, A.
    Cremolini, C.
    Loupakis, F.
    Lonardi, S.
    Casagrande, M. E.
    Murgioni, S.
    Salvatore, L.
    Masi, G.
    Fanotto, V.
    Granetto, C.
    Marmorino, F.
    Ginocchi, L.
    Ziampiri, S.
    Grande, R.
    Tonini, G.
    Delfanti, S.
    Di Donato, S.
    Fontanini, G.
    Boni, L.
    Zagonel, V.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [3] Efficacy and safety of bevacizumab (BEV) plus chemotherapy in Chinese patients (pts) with metastatic colorectal cancer (mCRC): Results from the ARTIST study.
    Guan, Z.
    Xu, J.
    Luo, R.
    Feng, F.
    Wang, L.
    Shen, L.
    Yu, S.
    Ba, Y.
    Liang, J.
    Wang, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Phase II randomized study of induction FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in metastatic colorectal cancer (mCRC): The MOMA trial
    Salvatore, Lisa
    Loupakis, Fotios
    Cremolini, Chiara
    Masi, Gianluca
    Bergamo, Francesca
    Gallano, Antonella
    Zagonel, Vittorina
    Ferrari, Laura
    Ongaro, Elena
    Cardellino, Giovanni
    Marcucci, Lorenzo
    Lucchesi, Sara
    Banzi, Maria
    Ciarlo, Andrea
    Miraglio, Emanuele
    Delfanti, Sara
    Corsi, Domenico C.
    Zaniboni, Alberto
    Tonlni, Giuseppe
    Falcone, Alfredo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Safety and efficacy of bevacizumab (BEV) and chemotherapy in elderly patients with metastatic colorectal cancer (mCRC): results from the BEAT observational cohort study
    Van Cutsem, E.
    Rivera, F.
    Berry, S.
    Kretzschmar, A.
    Michael, M.
    DiBartolomeo, M.
    Mazier, M. A.
    Georgoulias, V.
    Bridgewater, J.
    Cunningham, D.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 349 - 349
  • [6] Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer:a randomized phase Ⅲ ARTIST trial
    Zhong-Zhen Guan1
    2Sun Yat-sen University Cancer Center
    3307 Hospital of PLA
    4Guangzhou Nanfang Hospital
    5Cancer Institute & Hospital
    6Shanghai First People’s Hospital
    7Beijing Cancer Hospital
    8Tongji Hospital
    9Tianjin Medical University Cancer Institute and Hospital
    10The Affiliated Hospital of Medical College Qingdao University
    11Third Affiliated Hospital
    12The 81 Hospital of People’s Liberation Army
    13Shanghai Changzheng Hospital
    14Roche Product Development in Asia Pacific
    [J]. 癌症, 2011, 30 (10) : 682 - 689
  • [7] SAFETY AND EFFICACY OF BEVACIZUMAB (BEV) AND CHEMOTHERAPY IN ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): RESULTS FROM THE BEAT OBSERVATIONAL COHORT STUDY
    Van Cutsem, E.
    Rivera, F.
    Berry, S.
    Kretzschmar, A.
    Michael, M.
    DiBartolomeo, M.
    Mazier, M.
    Canon, J.
    Georgoulias, V
    Peeters, M.
    Bridgewater, J.
    Cunningham, D.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 18 - 18
  • [8] Chemotherapy plus Panitumumab Versus Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-analysis
    Li, Zhigui
    Huang, Yuqian
    Zhao, Rui
    Cui, Yaping
    Zhou, Yong
    Wu, Xiaoting
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [9] Chemotherapy plus Panitumumab Versus Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-analysis
    Zhigui Li
    Yuqian Huang
    Rui Zhao
    Yaping Cui
    Yong Zhou
    Xiaoting Wu
    [J]. Scientific Reports, 8
  • [10] A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer
    Hecht, J. Randolph
    Mitchell, Edith
    Chidiac, Tarek
    Scroggin, Carroll
    Hagenstad, Christopher
    Spigel, David
    Marshall, John
    Cohn, Allen
    McCollum, David
    Stella, Philip
    Deeter, Robert
    Shahin, Seta
    Amado, Rafael G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 672 - 680
12345